Crispr

Gene Info

• Species:Human (Homo sapiens)
• GeneID:6668
• Symbol:SP2
• Description:Sp2 transcription factor

DataSource: http://genomecrispr.dkfz.de/#!/results/SP2

Export (tab separated) Export to Excel

Start	The end	chr	strand	pubmed	cellline	condition	sequence	symbol	ensg	log2fc	rc_initial	rc_final	effect	cas	screentype	index
47896275	47896298	17	+	26627737	DLD1	viability	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-1.140211091737501	[252]	[11,102,0]	-7	hSpCas9	negative selection	798407
47896275	47896298	17	+	26627737	GBM cells	viability after 5 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	0.18292240981322075	[238]	[121,168]	3	hSpCas9	negative selection	880722
47896275	47896298	17	+	26627737	GBM cells	viability after 13 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	0.32265702635755006	[238]	[170,154]	4	hSpCas9	negative selection	963037
47896275	47896298	17	+	26627737	GBM cells	viability after 21 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	0.006043616715767648	[238]	[132,127]	0	hSpCas9	negative selection	1045352
47896275	47896298	17	+	26627737	RPE1	viability after 9 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-1.5962155461672096	[1122]	[69,175]	-8	hSpCas9	negative selection	1127667
47896275	47896298	17	+	26627737	RPE1	viability after 12 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-0.9834196487802953	[1122]	[189,112]	-6	hSpCas9	negative selection	1209982
47896275	47896298	17	+	26627737	RPE1	viability after 15 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-1.5543012885924	[1122]	[126,89]	-7	hSpCas9	negative selection	1292297
47896275	47896298	17	+	26627737	RPE1	viability after 18 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-1.1928773511570214	[1122]	[119,145]	-6	hSpCas9	negative selection	1374612
47896275	47896298	17	+	26627737	HeLa	viability after 8 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	1.271076166009469	[197]	[119,269,213]	8	hSpCas9	negative selection	1456927
47896275	47896298	17	+	26627737	HeLa	viability after 12 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-0.14779868911295435	[197]	[77,70,72]	-1	hSpCas9	negative selection	1539242
47896275	47896298	17	+	26627737	HeLa	viability after 15 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-0.41386704604278246	[197]	[36,69,75]	-4	hSpCas9	negative selection	1621557
47896275	47896298	17	+	26627737	HeLa	viability after 18 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-0.35143496725092604	[197]	[29,57,75]	-3	hSpCas9	negative selection	1703872
47896275	47896298	17	+	26627737	HCT116	viability after 6 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-0.15584179052461603	[708]	[81,109]	-1	hSpCas9	negative selection	1786187
47896275	47896298	17	+	26627737	HCT116	viability after 8 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	0.2526704847400233	[183]	[112,107,140]	3	hSpCas9	negative selection	1868502
47896275	47896298	17	+	26627737	HCT116	viability after 9 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-0.6509539387414223	[708]	[138,105]	-4	hSpCas9	negative selection	1950817
47896275	47896298	17	+	26627737	HCT116	viability after 12 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	0.31487026851189803	[183]	[99,176,86]	3	hSpCas9	negative selection	2033132
47896275	47896298	17	+	26627737	HCT116	viability after 15 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	0.3323640272788829	[183]	[230,124,55]	3	hSpCas9	negative selection	2115447
47896275	47896298	17	+	26627737	HCT116	viability after 18 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	0.6029031141495858	[183]	[149,182,65]	5	hSpCas9	negative selection	2197762
47896272	47896295	17	+	24336569	HL60	viability	GAGGAAGATGTCGTAATGAGCGG	SP2	ENSG00000167182	0.8210280310821054	[875]	[3274]	6	hSpCas9	negative selection	2296771
47896272	47896295	17	+	24336569	KBM7	viability	GAGGAAGATGTCGTAATGAGCGG	SP2	ENSG00000167182	-0.15216161686428542	[1394]	[3423]	-1	hSpCas9	negative selection	2363948
47896272	47896295	17	+	27661255	K562	viability	GAGGAAGATGTCGTAATGAGCGG	SP2	ENSG00000167182	-0.39799234305724895	[892,1105]	[642,569]	-7	dCas9-KRAB	negative selection	5513613
47896640	47896663	17	-	27661255	K562	viability	GACCCAGGCATAGTTCGCCCAGG	SP2	ENSG00000167182	-0.18450996861529498	[992,950]	[720,651]	-5	dCas9-KRAB	negative selection	5513614
47896275	47896298	17	+	27869803	HPAFII	viability after 27 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-0.12802845247867653	[225]	[189,40,NaN]	-1	hSpCas9	negative selection	9561425
47896275	47896298	17	+	27869803	HPAFII	viability after 15 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-0.5521419268794959	[225]	[185,152,NaN]	-5	hSpCas9	negative selection	9643874
47896275	47896298	17	+	27869803	ASPC1	viability after 36 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-2.011983824465983	[703]	[94,39,52]	-9	hSpCas9	negative selection	9726323
47896275	47896298	17	+	27869803	PATU8988S	viability after 35 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-2.2704268279932203	[514]	[38,46,NaN]	-9	hSpCas9	negative selection	9808772
47896275	47896298	17	+	27869803	PATU8988S	viability after 31 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-0.940891960897935	[514]	[157,41,NaN]	-7	hSpCas9	negative selection	9891221
47896275	47896298	17	+	27869803	HPAFII	viability after 35 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-1.3783996162469894	[225]	[59,25,NaN]	-6	hSpCas9	negative selection	9973670
47896275	47896298	17	+	27869803	HPAFII	viability after 31 days	GAAGATGTCGTAATGAGCGGTGG	SP2	ENSG00000167182	-0.24813641759886448	[225]	[157,50,NaN]	-2	hSpCas9	negative selection	10056119